PCB Technologies 2025: Growth Is Here, But Cash Hasn't Caught Up

Getting to Know the Company

At first glance, PCB Technologies looks like another defense-exposed electronics manufacturer enjoying the current demand cycle. That reading is too shallow. In practice, the group is trying to build a relatively broad hardware stack: printed circuit boards and substrates, electronics assembly, and a newer miniaturization activity in microelectronics. That matters because the economic engine of 2025 did not come only from higher demand. It also came from the ability to sell more layers of the same chain to customers, and to improve profitability in a place where many industrial manufacturers get stuck: the move from volume to higher-value work.

What is working right now is clear. Revenue rose to $181.6 million, gross profit climbed to $38.0 million, EBITDA reached $26.1 million, and the growth trend remained visible even in the fourth quarter. What is still not clean is that this improvement has not yet turned into real cash freedom. Working capital expanded, production-line investments continued, bank borrowing increased, and the company ended the year with $17.2 million drawn out of $18.5 million in bank facilities. That is the point an investor can easily miss if they stop at the order headlines and the defense growth story.

Another easy mistake is to assume the new story has already been settled by miniaturization. It has not. The segment is growing nicely, but it contributed only $8.6 million in 2025, or about 4% of consolidated revenue. The two core military customers in that segment accounted for about 74% of its revenue. In other words, there is a real option here, with more proof than before, but it is still far from being a broad and diversified business.

The simple version is that PCB Technologies enters 2026 in a genuinely interesting but still messy place. The traditional PCB and assembly activities are still the parts carrying scale, profit, and financing capacity. Miniaturization is the option that can change the company’s profile. The next test is whether the company can convert backlog and defense demand into cash without leaning even harder on banks and the balance sheet.

One short table frames the business map better than a generic description:

That last chart matters. It shows why the company’s improvement still cannot be read separately from the defense cycle. According to the presentation, 59% of the 2025 customer base came from defense and aerospace. That puts the company in the right place at the right time, but it also means a large part of the current acceleration is tied to one end market.

Events and Triggers

The first trigger: 2025 was a year of real operating acceleration. Revenue rose 18.8%, gross profit 36.2%, operating profit before other items 70.7%, and net income 54.2%. This is no longer just a rebound off a weak base. It is a year in which activity expanded and the operating system worked better.

The second trigger: the defense order flow through 2025 and early 2026 gives that improvement real support. In March 2025 the company received a roughly $3.9 million PCB order for a strategic defense project. A few days later it received another win with expected value of about $5.4 million. In June 2025 it received about $8.4 million of PCB orders for another strategic defense program, and later that month follow-on orders of about $11.6 million for electronics assembly on two defense projects. In November 2025 it won a tender worth about $12.8 million from a U.S. customer. Then came a $4.8 million miniaturization order in January 2026 and a roughly $7 million commercial agreement in March 2026. This is hard to dismiss as just marketing noise.

The third trigger: backlog is strong, but the mix is shifting. Near the report date, consolidated backlog after intersegment adjustments stood at about $137 million. On top of that, the company disclosed roughly $42 million of expected orders under multi-year framework agreements over about three years, bringing backlog plus expected orders to about $179 million. That is the headline number, but the mix matters just as much: PCB backlog moved from $56 million to $60 million, miniaturization from $7 million to $11 million, while assembly fell from $87 million to $71 million. The next growth leg may therefore come from a different internal mix than the one that powered 2025.

The fourth trigger: the control structure changed. FIMI sold a large block in July 2025, another block in December 2025, and the remainder on January 6, 2026. By the report date the company had no controlling shareholder. A few days later the board leadership also changed: Amir Vidman stepped down as chairman, Alon Granot replaced him, and Guy Shefran and Esther Barak Landes joined the board. This is not an immediate earnings driver, but it does change how 2026 should be read. Without a controlling shareholder, capital allocation, dividend discipline, and governance choices matter more.

Efficiency, Profitability and Competition

The most interesting 2025 datapoint is that the improvement in profitability did not come only from the new and more exciting segment. It came mainly from the less glamorous part of the group. Electronics assembly grew revenue by 29.2%, but its gross profit more than doubled, from $6.6 million to $14.0 million. That is a clear operating leverage story: better utilization, better execution, and a stronger customer mix. PCB revenue grew only 11% and added far less incremental gross profit, but it remains the engineering and manufacturing base that supports the whole company. Miniaturization grew 89% and raised gross profit from $1.3 million to $3.4 million, but economically it is still an add-on, not yet a replacement.

The gap between the full-year picture and the year-end run rate is also important. Fourth-quarter revenue rose 18.5% to $48.5 million, but fourth-quarter gross margin slipped to 19.4% from 20.7% a year earlier. Operating margin also eased to 8.4% from 9.4%. So the 2025 story is good, but the end of the year already shows that this model remains sensitive to mix, currency, and expansion costs.

Another layer is concentration quality. On the one hand, the company emphasizes a broad customer base. On the other, the credit-risk note says one customer accounts for about 30% of revenue. In miniaturization, two military customers accounted for about 74% of segment revenue. That is exactly the kind of concentration that can disappear inside a consolidated number. In a small and fast-growing segment, concentration is not unusual. But it does mean miniaturization has not yet moved from technical proof to broad commercial engine.

On competition, PCB Technologies is playing on something real: a relatively broad service chain, from PCBs and substrates through assembly and into microelectronics packaging. The company explicitly argues that, to the best of its knowledge, there is no player in Israel, Europe, or the U.S. offering that full range under one operating umbrella. That is a moat element, but not a clean one. In PCBs, local competition is still shaped by imports from the Far East, the U.S., and Europe, which make up about 74% of the Israeli market, and by the fact that some defense customers are pushed to produce in the U.S. because of offset obligations and U.S. aid structures. In other words, the company is not only fighting on price. It is fighting to stay relevant when customers are structurally nudged to buy elsewhere.

Currency is part of that story. The company states explicitly that a stronger shekel erodes profitability because most revenue is linked to the dollar or euro until delivery, while a meaningful share of wage and other costs is shekel-based. This is no longer theoretical. Net finance expense rose to $4.3 million in 2025 from $1.0 million in 2024, mainly because of accounting FX effects. That creates an important paradox: the business improved operationally, but part of the gain was lost in finance.

Cash Flow, Debt and Capital Structure

This is where the core issue sits. To keep the framing clean, it makes sense to use an all-in cash flexibility lens, meaning how much cash is left after the period’s real cash uses. On that basis, 2025 looks much less smooth than the income statement suggests.

Cash from operations came in at $7.8 million, versus net income of $13.1 million. The gap is not about an unusual accounting issue. It is about working capital. Receivables increased by $12.8 million, inventory by $3.5 million, while suppliers added only $2.1 million of support. Efficiency metrics tell the same story: customer credit days rose to 93 from 84, inventory days to 92 from 86, and supplier credit days fell to 108 from 114. The company is financing more customer credit, holding more inventory, and getting slightly less breathing room from suppliers.

From there the cash equation becomes tougher. $7.8 million of operating cash did not cover $8.8 million of property and equipment purchases, even after taking into account $1.4 million of investment grants and a net investing cash outflow of $8.2 million. On top of that came $2.4 million of total lease-related cash outflow and $5.3 million of dividends paid in June 2025. On an all-in basis, the business did not generate enough internal cash to fund growth, leases, and distributions at the same time.

The company bridged that gap through banks. Financing cash flow included a net $9.7 million increase in short-term bank credit, and year-end bank debt rose to $17.2 million from just $7.5 million a year earlier. At the same time, total bank facilities were expanded by $6 million to $18.5 million. This is not a signal of immediate distress, but it is a clear sign that 2025 growth was expensive in cash terms.

One short table puts the picture together:

The interesting part is that lenders already adapted the framework to this reality. Covenants are not tight today. The current ratio stands at 1.55 against a minimum of 1, tangible equity is 52% of assets against a 32% minimum, and tangible equity is around NIS 277 million against a NIS 100 million minimum. But one detail is hard to ignore: starting in the second quarter of 2025, the minimum current-ratio covenant was lowered from 1.25 to 1. That is not distress, but it is also not a footnote. It is evidence that even the banks saw growth pushing on working capital hard enough to justify more flexibility.

Leases add another layer. Lease liabilities stand at $14.2 million, and lease-related interest expense was $0.6 million. This is not balance-sheet stress by itself, but it is another real cash use that prevents net income from being treated as if it were freely distributable cash.

Outlook

First non-obvious finding: 2026 looks like a proof year, not a clean breakout year. Demand is strong, backlog is high, and the company sits on a real stream of defense orders. But to move into a cleaner story, it needs to prove not only that it can win and announce orders, but that it can convert them into growth without putting even more pressure on the balance sheet.

Second non-obvious finding: miniaturization is no longer just an idea, but it still cannot carry the thesis on its own. The segment ended 2025 with $8.6 million of revenue, $3.4 million of gross profit, $7 million of year-end backlog, and $11 million near the report date. The January and March 2026 disclosures add another roughly $11.8 million of order flow. That is real material for a proof year. Still, with 82% of 2025 segment revenue coming from military end markets, and with two customers making up 74% of the segment, any reading that already treats miniaturization as a mature growth engine is running ahead of the evidence.

Third non-obvious finding: the PCB capacity expansion is an opportunity, but also a capital test. The company approved about $6 million of investment to upgrade and expand certain PCB production arrays, with a targeted completion by the end of the third quarter of 2026 and a projected 40% to 60% increase in capacity. If demand stays strong, this can support another leg of growth. If conversion into revenue is slower, the company will be left with more investment, more inventory, and more bank usage before it sees the full return.

Fourth non-obvious finding: the end-of-2025 signal is not one-directional. On one side, operating profitability improved sharply. On the other, fourth-quarter margins were already less impressive, and finance expense was much heavier. That is exactly where the market can get the story wrong: reading 2025 as a clean normalization year when in practice it was a very good growth year but also a capital-intensive one.

What has to happen next? First, the new miniaturization orders need to convert into visible 2026 revenue without another outsized jump in receivables and inventory. Second, the assembly segment needs to hold a healthy activity level even after backlog there fell from $87 million to $71 million between year-end and the report date. Third, the PCB expansion has to stay on schedule, otherwise the company carries the expense before it gets the capacity benefit. Fourth, management expects a final emissions permit for the Migdal HaEmek plant by the end of the second quarter of 2026. That is not a demand issue, but it is a real operating chokepoint that needs to clear on time.

Two external variables also matter. One is currency. The company already showed in 2025 how a stronger shekel can eat into the model even when operating execution is good. The other is the U.S. The company says that, as of the report date, 15% tariffs had been imposed on goods imported from Israel into the U.S., but that it does not expect a material effect and can adjust pricing. This is not an immediate red flag, but it is a reminder that part of the international growth story will be tested not only by demand, but also by the ability to pass through new terms.

If the next year needs a label, it probably sits between a proof year and a transition year. A proof year because miniaturization and the broader expansion now have to show real commercial mass. A transition year because a meaningful share of the operating improvement is already visible, but the working capital, bank usage, and investment cycle are still in the middle of the process, not at the end.

Risks

The first risk is concentration, not only in the new segment but at group level. One customer accounts for about 30% of revenue. In miniaturization, two military customers account for about 74% of segment revenue. That does not mean the relationships are weak. It does mean any delay, rescheduling, or order change can show up faster at PCB Technologies than at a more diversified manufacturer.

The second risk is cash conversion and working capital. Inventory rose, customer days increased, and supplier days fell. At the same time, bank facilities were almost fully drawn. The company is still comfortably within covenants, but 2025 growth is already sitting directly on the balance sheet. If 2026 brings more growth without better cash conversion, the bank will not be the immediate problem, but strategic flexibility can erode.

The third risk is currency. Most revenue is dollar or euro linked until delivery, while part of the cost base is shekel-denominated. The company does run some hedging on wage expenses, and it recorded a $0.2 million hedge asset at year-end, but that is nowhere near enough to eliminate the exposure. 2025 already showed how good operating performance can meet a heavy finance line.

The fourth risk is growth quality. The external auditor flagged inventory valuation as the key audit matter, and inventory stood at $37.8 million at year-end. That does not prove an inventory problem. It does show that inventory is both material and complex enough to deserve special attention. In a fast-growing industrial name, that point should not be ignored.

The fifth risk is regulatory and operating friction. The company is still in the process of obtaining a final emissions permit for the Migdal HaEmek plant, with expected completion by the end of the second quarter of 2026. It also states that some buildings it uses do not have the proper building permits, or deviate from existing permits, and that fees and levies may be required. These are not thesis-breaking headlines, but they do remind investors that industrial expansion comes with real regulatory friction.

Conclusions

PCB Technologies exits 2025 with a better thesis than it had before. Growth is no longer built only on promises, operating profitability improved for real, and the company is sitting on backlog and order flow that support the reading that defense demand is helping. The main bottleneck remains cash: more inventory, more receivables, more credit, more CAPEX. In the short to medium term, the market is likely to focus mostly on whether the new orders, especially in miniaturization, begin to convert into revenue without another round of balance-sheet stretch.

Current thesis: PCB Technologies has proved it can grow and improve profit, but it has not yet proved that this growth can turn into free internal cash without leaning harder on bank lines.

What changed versus the older reading is the level of proof. Miniaturization has moved from a purely strategic story into one with revenue, gross profit, backlog, and concrete 2026-2027 orders. At the same time, the assembly segment showed in 2025 that it is still the most important economic engine inside the group.

Counter thesis: it is possible the company is simply at the front end of a multi-year upcycle, which would make the 2025 cash strain a normal transition cost rather than a structural problem. If the new capacity comes online on time, if miniaturization keeps scaling, and if defense orders move into regular deliveries, then the heavier working capital and bank usage of 2025 may look necessary in hindsight rather than worrying.

What could change the market’s reading over the short to medium term is a combination of three things: the revenue conversion of the new miniaturization orders, the behavior of working capital in the next reports, and the pace of progress on capacity expansion and the environmental permit. If those move in the right direction, the PCB Technologies story can clean up fairly quickly. If not, 2025 may later look like a year with a strong income statement but much more strain underneath.

Why this matters is that PCB Technologies is trying to move from being a good electronics manufacturer into a company with a higher-value technology layer on top of its industrial base. If that shift succeeds without wearing down the balance sheet, business quality improves materially. If it keeps coming with heavy working capital and high concentration, value creation remains only partial.

What has to happen over the next 2 to 4 quarters for the thesis to strengthen is straightforward: miniaturization needs to keep growing but also diversify; working capital needs to calm down; bank facilities need to stop tightening toward the edge; and the PCB investment needs to start showing up in capacity rather than only in cash outflow. What would weaken the thesis is another sharp rise in receivables and inventory, further pressure on quarter-end margins, or evidence that attractive order wins are not translating into deliveries and profitability.